Find out more about 𝐛𝐢𝐨𝐚𝐧𝐚𝐥𝐲𝐭𝐢𝐜𝐚𝐥 𝐚𝐬𝐬𝐚𝐲𝐬 in our upcoming webinar scheduled for Thursday, February 27 at 8am PT/11am ET/4pm GMT. We will be discussing the analytical challenges associated with the LC-MS bioanalysis of low molecular weight molecules (<200 amu) often associated with metabolomic measurements and analysis of biomarkers and metabolic products of drug biotransformations. By registering once, you will have access to and receive updates for each webinar in the series. 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐬𝐞𝐫𝐢𝐞𝐬 𝐡𝐞𝐫𝐞: https://lnkd.in/gnF442Jj For more information and to watch previous webinars, check out our page: https://lnkd.in/g5ACuqDp #DMPK #Webinar #Bioanalytical #Assays Hermes Licea-Perez Scott Summerfield
关于我们
Pharmaron (Stock Code: 300759.SZ/3759.HK) is a life sciences service provider. Founded in 2004, Pharmaron has invested in its people and facilities and has established a broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across multiple therapeutic modalities, including small molecules, biologics and CGT products. With over 21,000 employees and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners in North America, Europe, Japan and China. Services: * Synthetic, medicinal and analytical chemistry services * Biology services * DMPK services * Pharmacology services * Drug safety assessment services * Radiochemistry and isotopically labelled metabolism services * Chemical & pharmaceutical development services * Clinical development services www.pharmaron.com CRO - Contract Research Organization & CDMO - Contract Development Manufacturing Organization Library Synthesis CADD Bioorganic Chemistry Discovery Process Chemistry Radiolabelled Chemical Synthesis ChemInformatics in vitro Biology in vitro Screening Structural Biology in vivo Pharmacology Animal Disease Models ex vivo Pharmacology Biomarkers in vitro ADME in vivo PK PKPD QA Regulatory Affairs Discovery Biologics Process Chemistry API Manufacturing Material Science Formulation Development Drug Product Manufacturing Toxicology Safety Pharmacology Genetic Toxicology DART Pathology Immunotoxicity Bioanalytical 14C / Carbon-14 Radiosynthesis 3H / Tritium Radiosynthesis QWBA mARG Clinical AME Mass Balance Metabolite Profiling Microdosing Phase 0 Absolute Bioavailability DDI First-in-Human (FIH) Thorough QT(TQT) Ethnobridging
- 所属行业
- 制药业
- 规模
- 超过 10,001 人
- 总部
- Beijing
- 类型
- 私人持股
- 创立
- 2004
- 领域
- Chemistry、Biology、DMPK、Pharmacology、Chemical Development、Preclinical、Toxicology、Safety Pharmacology、Discovery、Lead Optimization、Process Development、Assay Development、ADME、Formulation、clinical pharmacology、analytical sciences、radiolabelled chemistry、accelerator mass spectrometry、radiolabelled compounds、API manufacturing、radiosynthesis、Biologics和CTG Products
地点
Pharmaron员工
动态
-
Pharmaron leverages cell painting technology and cutting-edge machine learning and bioinformatics to deliver powerful insights for drug discovery. This advanced technique is applicable for: > Phenotypic drug discovery > Target deconvolution > Analysis of signaling pathways > Understanding drug resistance mechanisms Our automated, high-throughput cell painting process uses the Operetta imaging system, and our skilled bioinformaticians analyze data in depth to provide clients with actionable insights. Interested in how cell painting can support your research? Download our latest case study profiling 390 kinase inhibitors here: https://lnkd.in/d9ZpyNDJ #DrugDiscovery #CellPainting #MachineLearning #Bioinformatics #HighThroughputScreening #TargetDeconvolution #Pharmaron
-
Pharmaron's comprehensive biologics services cover the entire development lifecycle - from discovery through clinical and commercial phases. Our expertise spans critical areas such as: > Protein science and antibody discovery for early-stage breakthroughs > In vivo pharmacology and PK/PD to optimize therapeutic performance > Large molecule bioanalysis and safety assessments for regulatory success > Full CDMO support to ensure efficient, scalable production With flexible solutions and a proven track record, we help our partners navigate every stage of biologics development with confidence. Connect with our experts to drive your biologics program forward: https://lnkd.in/dTwVtEWS #Biologics #CDMO #DrugDevelopment #Bioanalysis #Pharmacokinetics #AntibodyDiscovery #ProteinScience
-
Looking to advance your career in 2025? Pharmaron is hiring! Pharmaron is proud to deliver end-to-end solutions that help our partners bring innovative therapies to patients worldwide. From early pre-formulation to GMP clinical product manufacturing, our Drug Product Development teams are critical in advancing science and improving lives. As we reflect on an outstanding 2024, we’re focused on the future, which means growing our team with driven, passionate professionals like you. What sets Pharmaron apart? ✔ Comprehensive Expertise – Work alongside industry leaders in formulation, scale-up, and manufacturing. ✔ Cross-Functional Collaboration – Collaborate with API and DMPK teams to broaden your skills and impact. ✔ State-of-the-Art Facilities – Operate in cutting-edge pilot plants that deliver quality and efficiency. Take the next step: 🔗 Visit https://lnkd.in/erX42t5P to explore career opportunities. 📩 Email our Talent Acquisition team at talentacquisition@pharmaron.com to start the conversation. Whether you’re an experienced professional or seeking your next challenge, Pharmaron is where innovation meets opportunity. Join us, and together, let’s shape the future of drug development. #Pharmaron #DrugDevelopment #QualityExcellence #CareerGrowth #Innovation #Hiring #EndToEndSolutions #CRO #CDMO Pharmaron Biologics (UK) Ltd
🎉🌟 What a year it's been for Pharmaron UK Drug Product Development! 🌟🎉 2024 has been a fantastic year for the growth of our Drug Product Development team at Pharmaron UK. With an end-to-end service offering, we’re proud to support our clients throughout their clinical development program, from early pre-formulation through to GMP Clinical product manufacturing. Here’s what makes us unique: ✅ Expert Product Development Team – Creating innovative drug solutions tailored to patient needs. ✅ State-of-the-Art Pilot Plant – Providing seamless scale-up and manufacturing of OSD products. ✅ Unique Career Development opportunities – Product group works seamlessly & alongside our onsite API and DMPK teams providing employees with unique opportunities As we gear up for an even bigger 2025, we’re excited to announce that we’re expanding our team! We’re currently hiring for key roles, including: 📌Director / Senior Director Business Development – Drug Product 📌 Pilot Plant Technician 📌 Analytical Chemistry Lab Technician 📌 Technical Project Lead 📌 Senior Scientist – Drug Product (Analytical Chemistry) 📌 Scientist – Drug Product (Analytical Chemistry) If you’re ready to join a team that’s passionate about innovation, quality, and delivering real impact in drug development, we’d love to hear from you. Visit https://lnkd.in/erX42t5P.. or contact our Talent Acquisition team directly at: talentacquisition@pharmaron-uk.com to learn more about these exciting opportunities. Together, let’s make 2025 our best year yet! 🌟 #Pharmaron #PilotPlant #QualityExcellence #EndToEndSolutions #Hiring #drugproduct #formulation #CRO #CDMO
-
𝐊𝐢𝐜𝐤𝐬𝐭𝐚𝐫𝐭𝐢𝐧𝐠 𝟐𝟎𝟐𝟓 𝐰𝐢𝐭𝐡 𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐃𝐀𝐂𝐇 𝐑𝐞𝐠𝐢𝐨𝐧! At Pharmaron, we’re committed to advancing science and fostering connections. This Q1, we’re excited to participate in 𝐤𝐞𝐲 𝐞𝐯𝐞𝐧𝐭𝐬 across DACH, bringing together innovators, collaborators, and industry leaders. Upcoming Events Include: ✅ 𝐄𝐅𝐌𝐂-𝐈𝐒𝐂𝐁 𝟐𝟎𝟐𝟓 ✅ 𝐃𝐌𝐂𝐂𝐁 𝐁𝐚𝐬𝐞𝐥 𝐒𝐲𝐦𝐩𝐨𝐬𝐢𝐮𝐦 ✅ 𝐓𝐚𝐫𝐠𝐞𝐭 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 & 𝐍𝐨𝐯𝐞𝐥 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 ✅ 𝟗𝐭𝐡 𝐀𝐌𝐑 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝟐𝟎𝟐𝟓 ✅ 𝐒𝐰𝐢𝐬𝐬 𝐍𝐨𝐫𝐝𝐢𝐜 𝐁𝐢𝐨 ✅ 𝐏𝐡𝐚𝐫𝐦𝐚 𝐂𝐨𝐧𝐭𝐫𝐚𝐜𝐭 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐄𝐮𝐫𝐨𝐩𝐞 Whether you’re looking to learn more about our integrated drug discovery and development solutions or explore collaboration opportunities, we’d love to meet you at these events. Discover more about Pharmaron: https://lnkd.in/ewVsK4aU We hope to see you there! #Pharmaron #DACH #Switzerland #Networking #Innovation
-
Pharmaron is excited to be a Showcase Sponsor at BioSeed 2025! Join us on January 20th in London for this dynamic event where biotech innovators and investors come together to shape the future of life sciences. Our team - Filipa Antunes, Natalie Windle, and Kassim Kolia - will be there to connect, share insights, and discuss how Pharmaron’s comprehensive solutions can support your drug discovery and development journey. Don’t miss the chance to meet us and explore how we can help accelerate your research! See you at BioSeed 2025! OBN (UK) Ltd #Pharmaron #BioSeed2025 #Innovation #DrugDiscovery #LifeSciences
-
Pharmaron’s CGT Safety Assessment Services offer specialized toxicology solutions for both cell and gene therapy products. Our expertise includes: > Assessing toxicological profiles to ensure product safety and compliance > Specialized assays including cell morphology and differentiation evaluation > Comprehensive evaluation of in vivo and in vitro toxicity risks With tailored approaches and cutting-edge methodologies, we support every step of your cell and gene therapy development process. Learn more about how our safety assessment services can help streamline your path to success: https://lnkd.in/dV6N7HV3 #GeneTherapy #CellTherapy #CGTSafety #Pharmacology #Toxicology #DrugDevelopment
-
Take Your Cell and Gene Therapy Research to the Next Level with ELISpot Technology. Are you ready to explore the full potential of ELISpot and FluoroSpot in Cell & Gene Therapy studies? Whether you’re an experienced user or just starting out, this webinar is designed to deliver the insights and strategies you need to excel. Here’s what we’ll cover: -How to choose between single-plex and multiplex cytokine secretion analysis. -The unique advantages of Mabtech’s RAWspot Technology for precise spot counting. -Best practices for immunogenicity screening of biotherapeutics. -A comprehensive guide to ELISpot Method Qualification. -A real-world case study on ELISpot validation by Pharmaron that demonstrates how to save time and reduce costs. This is your chance to deepen your understanding of ELISpot technology and learn practical applications that can transform your research. Reserve your spot today and get ready to innovate! Register: https://lnkd.in/dEQ323Y5 Date: February 12, 2025 Time: 8 am PST | 11 am EST | 4 pm UTC #CellAndGeneTherapy #ELISpot #FluoroSpot #Biotherapeutics #Webinar
-
We're excited to announce the next issue of Pharmaron's Discovery News Newsletter—your gateway to the latest breakthroughs in drug discovery. Join us as we explore cutting-edge advancements that fast-track the discovery of small molecules and other emerging modalities. This is where innovation meets impact, and you're invited to be part of the journey. Don't miss out—subscribe today to deliver each issue directly to your inbox. Please share our insights with your friends and colleagues if they are valuable. Let's drive the future of drug discovery together. #Pharmaron #DrugDiscovery #Innovation #SmallMolecules #EmergingModalities #PharmaNews #SubscribeNow #ShareTheKnowledge
January 2025 Issue
Pharmaron,发布于领英
-
The holidays are behind us, and 2025 is here—it’s time to focus on your advanced therapies program! Our team is gearing up for Phacilitate, Advanced Therapies Week in Dallas, TX. Stop by Booth #675 to meet us and explore how we can partner to drive your programs forward. Click here to connect: https://lnkd.in/eAYEURPb #Pharmaron #AdvancedTherapiesWeek #Phacilitate #CellAndGeneTherapy #CGT #ATW25